Interpace Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.42	1.46	3.5	4.83	2.67	2.77
Cash & Short-Term Investments	1.42	1.46	3.5	4.83	2.67	2.77
Cash Growth	-32.66%	-58.23%	-27.55%	80.69%	-3.61%	19.43%
Accounts Receivable	5.97	8.54	5.08	5.03	4.67	8.03
Receivables	5.97	8.54	5.08	5.03	4.67	8.03
Inventory	1.1	1.21	1.23	1.22	0.83	2.05
Prepaid Expenses	0.58	0.54	0.59	0.39	0.58	0.63
Restricted Cash	-	-	-	-	0.25	0.6
Other Current Assets	0.05	0.02	0.02	0.68	3.16	0.05
Total Current Assets	9.13	11.77	10.42	12.15	12.17	14.12
Property, Plant & Equipment	2.86	2.97	2.65	2.92	1.6	11.73
Goodwill	-	-	-	-	-	8.43
Other Intangible Assets	-	-	-	0.86	2.13	11.35
Other Long-Term Assets	0.05	0.05	0.05	0.05	22.53	0.04
Total Assets	12.04	14.79	13.12	15.98	38.43	45.68
Accounts Payable	1.41	1.66	1.54	1.05	1.37	4.51
Accrued Expenses	2.26	3.33	3.01	7.9	9.04	8.34
Current Portion of Long-Term Debt	0.98	4.29	5.1	2.5	-	-
Current Portion of Leases	0.42	0.38	0.38	0.58	0.76	1.2
Current Income Taxes Payable	0.22	0.26	0.26	0.26	0.22	0.33
Current Unearned Revenue	-	-	-	-	-	0.05
Other Current Liabilities	0.66	0.7	1.15	1.99	4.28	3.8
Total Current Liabilities	5.95	10.62	11.44	14.28	15.68	18.23
Long-Term Debt	-	-	4.24	11.17	9.44	-
Long-Term Leases	0.86	1.18	1.47	1.85	0.52	3.54
Long-Term Unearned Revenue	-	-	-	-	-	0.14
Other Long-Term Liabilities	5.53	5.21	4.97	5.22	8.67	6.32
Total Liabilities	12.33	17.01	22.12	32.52	34.31	28.23
Common Stock	0.41	0.41	0.41	0.41	0.4	0.4
Additional Paid-In Capital	234.83	234.81	188.15	187.52	186.11	184.4
Retained Earnings	-233.46	-235.38	-242.08	-249.02	-227.06	-212.12
Treasury Stock	-2.07	-2.05	-2.01	-1.98	-1.87	-1.77
Total Common Equity	-0.3	-2.22	-55.54	-63.07	-42.42	-29.08
Shareholders' Equity	-0.3	-2.22	-9	-16.54	4.12	17.45
Total Liabilities & Equity	12.04	14.79	13.12	15.98	38.43	45.68
Total Debt	2.26	5.86	11.19	16.09	10.72	4.74
Net Cash (Debt)	-0.84	-4.4	-7.69	-11.26	-8.05	-1.97
Net Cash Per Share	-0.03	-0.28	-1.76	-2.66	-1.95	-0.49
Filing Date Shares Outstanding	4.43	4.42	4.38	4.31	4.23	4.11
Total Common Shares Outstanding	4.43	4.41	4.35	4.3	4.2	4.06
Working Capital	3.19	1.16	-1.02	-2.13	-3.52	-4.11
Book Value Per Share	-0.07	-0.50	-12.76	-14.68	-10.11	-7.17
Tangible Book Value	-0.3	-2.22	-55.54	-63.93	-44.55	-48.87
Tangible Book Value Per Share	-0.07	-0.50	-12.76	-14.88	-10.62	-12.05
Machinery	-	3.47	2.81	2.55	2.22	8.21
Leasehold Improvements	-	0.48	0.27	0.18	0.18	0.51

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.